Oppenheimer analyst Francois Brisebois reiterated an Outperform rating and $16.00 price target on Abeona Therapeutics (NASDAQ: ABEO)The analyst comments "ABEO ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE